Commodore Capital LP - 26 Sep 2025 SCHEDULE 13G Report for SAB BIOTHERAPEUTICS, INC. Common Stock, $0.0001 par value per share (SABS)

Filing Manager
Commodore Capital LP
Reporting Manager
Commodore Capital LP
Security
SAB BIOTHERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol
SABS
Shares outstanding
45.7M shares
Disclosed Ownership
4.52M shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
03 Oct 2025, 16:05:22 UTC
Date of event
26 Sep 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Commodore Capital LP 9.9% 4.52M 0 4.52M /s/ Michael Kramarz Managing Partner
Commodore Capital Master LP 9.9% 4.52M 0 4.52M /s/ Michael Kramarz Authorized Signatory
Robert Egen Atkinson 9.9% 4.52M 0 4.52M /s/ Robert Egen Atkinson Authorized Signatory
Michael Kramarz 9.9% 4.52M 0 4.52M /s/ Michael Kramarz Authorized Signatory